MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
+9.81%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$23.8B
AUM Growth
-$298M
(-1.2%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-9.77%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
1,984
New
497
Increased
347
Reduced
441
Closed
584
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$156M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 3 |
Salesforce
CRM
|
+$143M |
| 4 |
IBM
IBM
|
+$133M |
| 5 |
Dell
DELL
|
+$115M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$333M |
| 2 |
Apple
AAPL
|
+$218M |
| 3 |
Intel
INTC
|
+$175M |
| 4 |
Zoom
ZM
|
+$171M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$163M |
Sector Composition
| 1 | Healthcare | 23.6% |
| 2 | Technology | 18.15% |
| 3 | Communication Services | 13.77% |
| 4 | Consumer Discretionary | 12.83% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Copa Holdings
CPA
$4.86B
| $251K | ﹤0.01% |
+3,329
| New | +$251K |
|
1252
Churchill Downs
CHDN
$6.75B
| $250K | ﹤0.01% |
+2,526
| New | +$250K |
|
1253
Beyond Meat
BYND
$205M
| $249K | ﹤0.01% |
1,578
-19,112
| -92% | -$3.02M |
|
|
ETRN
1254
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $248K | ﹤0.01% |
+29,169
| New | +$248K |
|
1255
iHeartMedia
IHRT
$389M
| $247K | ﹤0.01% |
+9,178
| New | +$247K |
|
|
CCVI
1256
DELISTED
Churchill Capital Corp VI
CCVI
| $247K | ﹤0.01% |
+25,000
| New | +$247K |
|
1257
Anterix
ATEX
$395M
| $243K | ﹤0.01% |
4,030
-5,605
| -58% | -$338K |
|
1258
Apellis Pharmaceuticals
APLS
$3.14B
| $241K | ﹤0.01% |
3,809
-18,953
| -83% | -$1.2M |
|
1259
America's Car Mart
CRMT
$286M
| $241K | ﹤0.01% |
+1,704
| New | +$241K |
|
|
GTY
1260
Getty Realty Corp
GTY
$1.6B
| $239K | ﹤0.01% |
+7,670
| New | +$239K |
|
1261
Workhorse Group
WKHS
$17.7M
| $239K | ﹤0.01% |
+58
| New | +$239K |
|
1262
Zumiez
ZUMZ
$347M
| $238K | ﹤0.01% |
+4,867
| New | +$238K |
|
1263
Avis
CAR
$5.47B
| $237K | ﹤0.01% |
+3,034
| New | +$237K |
|
1264
Payoneer
PAYO
$2.34B
| $236K | ﹤0.01% |
+22,732
| New | +$236K |
|
|
YTEN
1265
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $231K | ﹤0.01% |
1,130
-182
| -14% | -$37.2K |
|
1266
Nabors Industries
NBR
$617M
| $230K | ﹤0.01% |
2,013
-4,058
| -67% | -$464K |
|
1267
Cushman & Wakefield
CWK
$3.85B
| $229K | ﹤0.01% |
13,100
-3,432
| -21% | -$60K |
|
1268
The Greenbrier Companies
GBX
$1.42B
| $228K | ﹤0.01% |
+5,225
| New | +$228K |
|
1269
Belden
BDC
$5.21B
| $226K | ﹤0.01% |
+4,447
| New | +$226K |
|
1270
Adaptive Biotechnologies
ADPT
$1.92B
| $225K | ﹤0.01% |
5,498
-26,698
| -83% | -$1.09M |
|
1271
Arrowhead Research
ARWR
$4.11B
| $224K | ﹤0.01% |
+2,710
| New | +$224K |
|
|
NS
1272
DELISTED
NuStar Energy L.P.
NS
| $224K | ﹤0.01% |
+12,416
| New | +$224K |
|
1273
Exact Sciences
EXAS
$10.2B
| $223K | ﹤0.01% |
1,792
-19,646
| -92% | -$2.44M |
|
|
DSPG
1274
DELISTED
DSP Group Inc
DSPG
| $223K | ﹤0.01% |
+15,066
| New | +$223K |
|
1275
Repligen
RGEN
$6.39B
| $219K | ﹤0.01% |
1,095
-150,149
| -99% | -$30M |
|